FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diazepam Oral Solution (Concentrate)
Status: Discontinuation
»Therapeutic Categories: Neurology

Lannett Company, Inc. (New 01/05/2022)

Company Contact Information:

Presentation Posting Date Related Information
5 mg/mL (NDC 0527-1768-36) 01/05/2022 Lannett has made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English